New treatment option for Subarachnoid Hemorrhage, Aneurysmal
Official title Remote Ischemic Conditioning in Aneurysmal SAH
ClinicalTrials.gov ID: NCT06032533
What this study is testing
- What it's testing
- The goal of this clinical trial is to examine the effect of limb occlusion therapy (remote ischemic conditioning, RIC) in subjects with aneurysmal subarachnoid hemorrhage. The main question it aims to answer is whether RIC can improve long-term recovery in participants with aneurysmal subarachnoid hemorrhage.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aneurysmal subarachnoid hemorrhage confirmed by computed tomography (CT) with aneurysm origin confirmed by computed tomography angiography (CTA) or...
- Aneurysmal subarachnoid hemorrhage symptom-onset ≤ 3 days
- Aneurysm protected by clipping or coiling
- Independent in daily living before symptom onset (mRS ≤ 2)
You likely can't join if
- Subarachnoid hemorrhage caused by a lesion other than cerebral aneurysm
- Symptomatic vasospasm at the time of enrollment
- Previous cerebral lesion e.g. symptomatic cerebral infarction (\>2cm), multiple sclerosis, symptomatic intracerebral hemorrhage, tumour, prior...
- History of severe peripheral vascular disease or signs of severe peripheral vascular disease on physical examination
- History of deep vein thrombosis or signs of deep vein thrombosis on physical examination
- Kidney involvement or prior kidney disease with an estimated glomerular filtration rate (eGFR) below safe levels for contrast infusion in relation to...
See the full eligibility criteria
- Aneurysmal subarachnoid hemorrhage confirmed by computed tomography (CT) with aneurysm origin confirmed by computed tomography angiography (CTA) or digital subtraction angiography (DSA)
- Aneurysmal subarachnoid hemorrhage symptom-onset ≤ 3 days
- Aneurysm protected by clipping or coiling
- Independent in daily living before symptom onset (mRS ≤ 2)
- Subarachnoid hemorrhage caused by a lesion other than cerebral aneurysm
- Symptomatic vasospasm at the time of enrollment
- Previous cerebral lesion e.g. symptomatic cerebral infarction (\>2cm), multiple sclerosis, symptomatic intracerebral hemorrhage, tumour, prior neurosurgery (excluding prior clipping or coiling of cold aneurysms without...
- History of severe peripheral vascular disease or signs of severe peripheral vascular disease on physical examination
- History of deep vein thrombosis or signs of deep vein thrombosis on physical examination
- Kidney involvement or prior kidney disease with an estimated glomerular filtration rate (eGFR) below safe levels for contrast infusion in relation to CT-perfusion.
- Pregnancy (Women of child-bearing age will have serum-Humane Choriogonadotropine taken prior to final inclusion. If pregnancy cannot be ruled out,the patient can't be included. Women with a safe birth control method...
- Concomitant other acute life-threatening medical or surgical condition
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus N, Danmark, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus N, Danmark, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.